
As a key member of our regulatory affairs team, you will efficiently drive the regulatory evaluation, feasibility, strategy, and gap analysis for pipeline products to execute quality product registration for the Australia and New Zealand market.
You will also assist the Scientific Affairs Director in the leadership and development of the regulatory affairs team and provide strategic guidance to the business with your in-depth understanding of regulatory requirements.
Your responsibilities include, but not limited to:
Commitment to Diversity & Inclusion:
Sandoz is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
What you’ll bring to the role:
Why Sandoz?
Generic and biosimilar medicines are the backbone of the healthcare industry, and Sandoz touches the lives of nearly 500 million patients globally each year. While we are proud of this impact, we are driven to do more. Through investments in development capabilities, state-of-the-art production sites, strategic acquisitions, and partnerships, we are shaping the future of affordable, high-quality medicines.
Our momentum is powered by an open, collaborative culture and a team of talented, ambitious associates. We foster an agile and inclusive environment where diversity is valued, innovation is encouraged, and personal growth is supported.
Locally, we are proud to have achieved four consecutive Great Place to Work® certifications and to be recognised as the #1 Best Workplace in Pharmaceuticals & Biotechnology in Australia for 2025.
Skills Desired
Data Analysis, Documentation Management, Lifesciences, Regulatory Compliance, Waterfall Project Management

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc